45
Participants
Start Date
February 28, 1994
Primary Completion Date
April 30, 2002
Study Completion Date
April 30, 2002
Recombinant Interferon Alfa
Daily
Cyclophosphamide
Infused intravenously over 2 hours daily on Day -7 and -6.
Etoposide
Administered intravenously on Day -8
Mesna
Beginning 1 hour after initiation of the cyclophosphamide treatment.
Bone Marrow Transplantation
Infusion on Day 0.
Radiation Therapy
Total body irradiation is received on days -4, -3, -2 , and -1.
University of Texas - MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER